Skip to main content
Erschienen in: Current Urology Reports 9/2023

14.06.2023

Prostatic Arterial Embolization for Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement

verfasst von: Patrick Curtin, Christopher Chang, Andre Uflacker

Erschienen in: Current Urology Reports | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Prostatic artery embolization (PAE) is an emerging minimally invasive technique for lower urinary tract symptom reduction from benign prostatic hypertrophy (BPH). While the technique is becoming increasingly popular with patients and interventional radiologists, most urologists remain skeptical of the PAE’s long-term efficacy and comparative success to the gold standard transurethral resection of the prostate.

Recent Findings

PAE has been found in multiple meta-analyses to perform similarly to the gold standard transurethral resection of the prostate (TURP) with regard to patient-driven measures like IPSS and IPSS-QoL, while also performing favorably in objective measurements including Qmax and PVR out to at least 12 months post intervention. Furthermore, PAE has a demonstrated shorter hospital length of stay and fewer adverse events when compared to TURP.

Summary

PAE provides patients with an alternative to transurethral options for the management of LUTS in the setting of bladder outlet obstruction. While long-term evidence demonstrating the durability of PAE is still forthcoming, the procedure has been demonstrated to be safe according to multiple meta-analyses. Patients deserve to be counseled on PAE as an alternative to surgery and made aware that while the overall treatment effect may not be as robust or durable, the procedure carries a favorable adverse event profile that is attractive to patients wishing to avoid a trans-urethral approach.
Literatur
1.
Zurück zum Zitat Carnevale FC, Antunes AA, Da Motta Leal Filho JM, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010;33(2):355–361. https://doi.org/10.1007/s00270-009-9727-z. Carnevale FC, Antunes AA, Da Motta Leal Filho JM, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010;33(2):355–361. https://​doi.​org/​10.​1007/​s00270-009-9727-z.
2.
Zurück zum Zitat Demeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia- transarterial polyvinyl alcohol prostate embolization 1. J Vasc Interv Radiol. 2000;11:767–70.CrossRefPubMed Demeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia- transarterial polyvinyl alcohol prostate embolization 1. J Vasc Interv Radiol. 2000;11:767–70.CrossRefPubMed
32.
Zurück zum Zitat Franco J, Jung J, Imamura M, et al. Minimally invasive treatments for lower urinary tract symptoms inmen with benign prostatic hyperplasia: a network meta-analysis(review). Cochrane Database Syst Rev. 2021;2021(12). Franco J, Jung J, Imamura M, et al. Minimally invasive treatments for lower urinary tract symptoms inmen with benign prostatic hyperplasia: a network meta-analysis(review). Cochrane Database Syst Rev. 2021;2021(12).
34.
Zurück zum Zitat Jiang Y-L, Qian L-J. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis. BMC Urol. 2019;19(11). Jiang Y-L, Qian L-J. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis. BMC Urol. 2019;19(11).
36.
Zurück zum Zitat •• Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2021;44(2):183–93. https://doi.org/10.1007/s00270-020-02657-5. Interesting meta-analysis in which PAE was equally efficacious when compared to gold standard TURP in terms of improvement in both objective and subjective categories including IPSS, IPSS-QoL, IIEF-5, and PVR while having a significantly shorter hospital length of stay and fewer adverse events.CrossRefPubMed •• Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2021;44(2):183–93. https://​doi.​org/​10.​1007/​s00270-020-02657-5. Interesting meta-analysis in which PAE was equally efficacious when compared to gold standard TURP in terms of improvement in both objective and subjective categories including IPSS, IPSS-QoL, IIEF-5, and PVR while having a significantly shorter hospital length of stay and fewer adverse events.CrossRefPubMed
37.
Zurück zum Zitat Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;361. https://doi.org/10.1136/bmj.k2338. Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;361. https://​doi.​org/​10.​1136/​bmj.​k2338.
38.
Zurück zum Zitat Ray AF, Powell J, Speakman MJ, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122(2):270–82. https://doi.org/10.1111/bju.14249.CrossRefPubMed Ray AF, Powell J, Speakman MJ, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122(2):270–82. https://​doi.​org/​10.​1111/​bju.​14249.CrossRefPubMed
39.
Zurück zum Zitat •• LaRussa S, Pantuck M, Wilcox Vanden Berg R, Gaffney CD, Askin G, McClure T. Symptomatic improvement of lower urinary tract symptoms of benign prostatic hyperplasia: a comparative systematic review and meta-analysis of 4 different minimally invasive therapies. J Vasc Interv Radiol. 2021;32(9):1328–1340.e11. https://doi.org/10.1016/j.jvir.2021.06.019. Unique article comparing multiple minimally invasive techniques including prostatic artery embolization (PAE), photoselective vaporization (PVP), prostatic urethral lift (PUL), and water vapor thermal therapy (WV). PAE performed significantly better than PUL and WV in IPSS and QOL after 6 months, and was the only modality that showed continued improvement in these measures between 6 and 12 months. Only PAE resulted in improved IIEF. •• LaRussa S, Pantuck M, Wilcox Vanden Berg R, Gaffney CD, Askin G, McClure T. Symptomatic improvement of lower urinary tract symptoms of benign prostatic hyperplasia: a comparative systematic review and meta-analysis of 4 different minimally invasive therapies. J Vasc Interv Radiol. 2021;32(9):1328–1340.e11. https://​doi.​org/​10.​1016/​j.​jvir.​2021.​06.​019. Unique article comparing multiple minimally invasive techniques including prostatic artery embolization (PAE), photoselective vaporization (PVP), prostatic urethral lift (PUL), and water vapor thermal therapy (WV). PAE performed significantly better than PUL and WV in IPSS and QOL after 6 months, and was the only modality that showed continued improvement in these measures between 6 and 12 months. Only PAE resulted in improved IIEF.
51.
Zurück zum Zitat • Yuan B, Wang Y, Wang MQ, et al. Prostate artery embolization for the treatment of urinary retention caused by large (>80 mL) benign prostatic hyperplasia: results of 21 patients. J Interv Med. 2020;3(3):142–5. https://doi.org/10.1016/j.jimed.2020.07.007. Single center study in which PAE was utilized in prostatomegaly with prostate volume >80mL. There was overall a 95% success rate for catheter removal with spontaneous voiding at 3 months following intervention. This success was maintained out to 12 months post procedure.CrossRefPubMedPubMedCentral • Yuan B, Wang Y, Wang MQ, et al. Prostate artery embolization for the treatment of urinary retention caused by large (>80 ​mL) benign prostatic hyperplasia: results of 21 patients. J Interv Med. 2020;3(3):142–5. https://​doi.​org/​10.​1016/​j.​jimed.​2020.​07.​007. Single center study in which PAE was utilized in prostatomegaly with prostate volume >80mL. There was overall a 95% success rate for catheter removal with spontaneous voiding at 3 months following intervention. This success was maintained out to 12 months post procedure.CrossRefPubMedPubMedCentral
Metadaten
Titel
Prostatic Arterial Embolization for Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement
verfasst von
Patrick Curtin
Christopher Chang
Andre Uflacker
Publikationsdatum
14.06.2023
Verlag
Springer US
Erschienen in
Current Urology Reports / Ausgabe 9/2023
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-023-01170-9

Weitere Artikel der Ausgabe 9/2023

Current Urology Reports 9/2023 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.